Results 41 to 50 of about 1,384,561 (311)

Assessment of food-related knowledge and preferred awareness methods by the Saudi community: a cross-sectional study

open access: yesBMC Public Health
Background Food safety and healthy food are linked to each other: to be healthy, people must eat nourishing food that doesn’t carry foodborne diseases (FBDs).
Moudhi Almutlaq   +5 more
doaj   +1 more source

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Uremic toxins are a growing area of research in nephrology, with significant implications in the progression and treatment of chronic kidney disease (CKD) and the management of end‐stage kidney disease (ESKD). This bibliometric analysis aims to evaluate the global research trends, key contributors, and the impact of publications in ...
Yuh‐Shan Ho   +7 more
wiley   +1 more source

PFAS in first-time mothers from Sweden: temporal trends and the impact from fish/seafood consumption and drinking water exposure

open access: yesEnvironment International
Per- and polyfluoroalkyl substance (PFAS)-contaminated drinking water has been a significant source of human exposure to PFAS in Uppsala, Sweden. Herein, we investigated temporal trends of PFAS in serum samples collected three weeks after delivery from ...
Irina Gyllenhammar   +7 more
doaj   +1 more source

Recommendations for benefit-risk assessment methodologies and visual representations. [PDF]

open access: yes, 2015
PURPOSE: The purpose of this study is to draw on the practical experience from the PROTECT BR case studies and make recommendations regarding the application of a number of methodologies and visual representations for benefit-risk assessment.
Hallgreen, CE   +15 more
core   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Validation of the web-based dietary assessment tool (RiksmatenFlex) against doubly labelled water and 24-h dietary recalls in Swedish pre-school children

open access: yesNutrition Journal
Background RiksmatenFlex, a Swedish’ web-based dietary assessment method, has previously been validated in adolescents and pregnant women. The aim of this study was to evaluate RiksmatenFlex in preschool children by comparing energy intake with total ...
Anna Karin Lindroos   +6 more
doaj   +1 more source

Matrix Effect Variability in Urine Samples from Different Cohorts and Implications on LC-ESI-MS Mycotoxin Biomarker Analysis

open access: yesToxins
Matrix effects (ME) during LC-ESI-MS analysis are a commonly acknowledged issue for a variety of matrices and analytes. Although sample preparation techniques are steadily evolving to reduce ME, the complexity and variability of the urine matrix remain a
Michael Kuhn   +5 more
doaj   +1 more source

Establishing an Apheresis Medicine Program in a Resource‐Constrained Setting: A 5‐Year Experience From Lagos, Nigeria

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola   +4 more
wiley   +1 more source

Evaluating integration in collaborative cross-disciplinary FDA new drug reviews using an input-process-output model

open access: yesJournal of Clinical and Translational Science, 2021
Background/Objectives: The US Food and Drug Administration (FDA) is responsible for assessing safety (risks) and effectiveness (benefits) of new drug products using the data provided in a Sponsor’s new drug product marketing application before they can ...
Kevin Bugin   +3 more
doaj   +1 more source

Does Mitigation Save? Reviewing cost-1 benefit analyses of disaster risk reduction [PDF]

open access: yes, 2014
The benefit-cost-ratio (BCR), used in cost-benefit analysis (CBA), is an indicator that attempts to summarize the overall value for money of a project.
Shreve, Cheney   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy